You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pertuzumab

Showing 1 - 25 of 355
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HER2-PositiveRecurrent or Metastatic Breast Cancer Trial (SHR-A1811 Injection, SHR-A1811 Injection ; Pertuzumab Injection,

Not yet recruiting
  • HER2-PositiveRecurrent or Metastatic Breast Cancer
  • SHR-A1811 Injection
  • +2 more
  • (no location specified)
Sep 21, 2023

Malignant Solid Tumor Trial in Philadelphia (Biopsy, Biospecimen Collection, Echocardiography)

Active, not recruiting
  • Malignant Solid Neoplasm
  • Biopsy
  • +5 more
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
Nov 15, 2023

Healthy Men Trial in Moscow (Pertuzumab, Perjeta®)

Not yet recruiting
  • Healthy Men
  • Moscow, Russian Federation
    Central Clinical Hospital "RZD-Medicina"
Apr 11, 2023

Locally Advanced Breast Cancer, Chemo Effect Trial in Beijing (inetetamab with pertuzumab and paclitaxel/carboplatin (TCbIP)

Recruiting
  • Locally Advanced Breast Cancer
  • Chemotherapy Effect
  • inetetamab with pertuzumab and paclitaxel/carboplatin (TCbIP) regimen
  • Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Feb 28, 2023

Metastatic Breast Cancer Trial (BDC-1001, Pertuzumab)

Not yet recruiting
  • Metastatic Breast Cancer
  • (no location specified)
Jul 12, 2023

Metastatic HER2-Positive Breast Cancer Trial in United States (Gemcitabine, Trastuzumab, Pertuzumab)

Active, not recruiting
  • Metastatic HER2-Positive Breast Cancer
  • Hartford, Connecticut
  • +4 more
Dec 1, 2022

Breast Cancer Trial in Shanghai (Pertuzumab)

Not yet recruiting
  • Breast Cancer
  • Pertuzumab
  • Shanghai, Shanghai, China
    Shanghai Jiaotong University School of Medicine affiliated Ruiji
Jun 4, 2023

Pyrotinib Plus Trastuzumab Versus Pertuzumab Plus Trastuzumab

Active, not recruiting
  • Breast Cancer
  • Pyrotinib Plus Trastuzumab
  • Pertuzumab Plus Trastuzumab
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Oct 5, 2022

Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Scottsdale, Jacksonville, Rochester

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • Stage IVB Prostate Cancer AJCC v8
  • Biopsy
  • +7 more
  • Scottsdale, Arizona
  • +2 more
Feb 15, 2023

Metastatic Breast Cancer Trial (Pertuzumab (ZRC-3277), Pertuzumab (Perjeta®))

Not yet recruiting
  • Metastatic Breast Cancer
  • Pertuzumab (ZRC-3277)
  • Pertuzumab (Perjeta®)
  • (no location specified)
Jul 11, 2022

HER2-positive Breast Cancer, Leptomeningeal Metastasis, Leptomeningeal Disease Trial in Tampa, Evanston (Radiation Therapy,

Recruiting
  • HER2-positive Breast Cancer
  • +2 more
  • Radiation Therapy
  • +2 more
  • Tampa, Florida
  • +1 more
Dec 30, 2022

Breast Cancer Trial in Shanghai (Dalpiciclib, Fulvestrant, Pertuzumab)

Active, not recruiting
  • Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Oct 10, 2022

HER2-positive Breast Cancer Trial in Guanzhou (Eribulin mesylate injection?Pertuzumab?Trastuzumab)

Recruiting
  • HER2-positive Breast Cancer
  • Eribulin mesylate injection、Pertuzumab、Trastuzumab
  • Guanzhou, Guangdong, China
    LI YuDong
Jul 13, 2023

Breast Cancer Trial in Berlin (420 mg EG1206A EirGenix Pertuzumab in 14 mL Injection, Perjeta (EU origin) 420 mg in 14 mL

Recruiting
  • Breast Cancer
  • 420 mg EG1206A EirGenix Pertuzumab in 14 mL Injection
  • +2 more
  • Berlin, Germany
    CRS Clinical Research Services Berlin GmbH
Jul 20, 2022

Breast Cancer Trial in Shanghai (Pegylated liposomal doxorubicin, Epirubicin, Cyclophosphamid)

Recruiting
  • Breast Cancer
  • Pegylated liposomal doxorubicin
  • +5 more
  • Shanghai, China
    Shanghai Pudong Hospital
Dec 11, 2022

Healthy Male Subjects Trial in Auckland, Christchurch (Fixed-Dose Combination of Pertuzumab and Trastuzumab SC (PH FDC SC),

Recruiting
  • Healthy Male Subjects
  • Fixed-Dose Combination of Pertuzumab and Trastuzumab SC (PH FDC SC)
  • +2 more
  • Adelaide, South Australia, Australia
  • +3 more
Feb 1, 2023

Breast Tumors, Malignant Tumor of the Breast Trial in Multiple Locations (Trastuzumab, Pertuzumab, Vinorelbine, Paclitaxel,

Terminated
  • Breast Neoplasms
  • Malignant Tumor of the Breast
  • Multiple Locations, Texas
    19 Sites
Nov 29, 2022

Breast Cancer Trial in Houston (Durvalumab, Trastuzumab, Pertuzumab)

Recruiting
  • Breast Cancer
  • Houston, Texas
    Houston Methodist Cancer Center
Aug 5, 2022

Breast Cancer Trial in Shenyang (Pyrotinib, Trastuzumab, Dalpiciclib)

Not yet recruiting
  • Breast Cancer
  • Shenyang, Liaoning, China
    Shengjing Hospital of China Medical University
Dec 2, 2022

HER2 Positive Early Breast Cancer Trial in Shanghai (Docetaxel, carboplatin, Trastuzumab)

Recruiting
  • HER2 Positive Early Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center Shanghai, China, 200032
Jun 6, 2023

HER2-positive Breast Cancer Trial in Tampa (biological, drug, procedure)

Recruiting
  • HER2-positive Breast Cancer
  • HER-2 pulsed DC1
  • +4 more
  • Tampa, Florida
    Moffitt Cancer Center
Oct 6, 2022

Esophageal Cancer, Esophageal Adenocarcinoma Trial in Amsterdam (Trastuzumab, Pertuzumab, Paclitaxel)

Recruiting
  • Esophageal Cancer
  • Esophageal Adenocarcinoma
  • Amsterdam, Netherlands
    Academic Medical Center
Jun 18, 2022

Breast Cancer Trial in Saint Petersburg (BCD-178, Perjeta)

Active, not recruiting
  • Breast Cancer
  • Saint Petersburg, Russian Federation
  • +1 more
Feb 13, 2023

HER2-positive Breast Cancer Trial in Shanghai (SYSA1901, Pertuzumab, Trastuzumab)

Recruiting
  • HER2-positive Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Feb 8, 2023

Brain Metastases, Human Epidermal Growth Factor 2 Positive Carcinoma of Breast, Advanced Breast Cancer Trial (Trastuzumab,

Recruiting
  • Brain Metastases
  • +2 more
  • Saint Louis, Missouri
  • +1 more
Nov 8, 2022